Accredo Health Group, Inc.
Memphis, TN
- UEI
- LERPSGUE3528
- CAGE
- 4NU29
- Primary NAICS
- 456110 Pharmacies and Drug Retailers
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Express Scripts Inc, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1640 Century Center Pkwy #105, Memphis, TN 38134, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$10,382 |
| FY2025 | $38,137 |
| FY2024 | $1,065,844 |
| FY2023 | $1,269,948 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Caremark RX, L.L.C. | Mount Prospect, IL | 456110 Pharmacies and Drug Retailers |
| Optum Pharmacy 601, LLC | — | 325412 Pharmaceutical Preparation Manufacturing |
| Astor Drugs | Holtsville, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Richmond Pharmaceuticals, Inc. | Richmond, VA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Accredo Health Group, Inc., a for-profit pharmacy benefit management company based in Memphis, Tennessee, and a subsidiary of Express Scripts, specializes in distributing complex, high-value specialty pharmaceutical products to federal agencies, particularly the Department of Veterans Affairs. The company has maintained active federal contracting relationships since its SAM.gov registration on February 19, 2007, and holds a current registration valid through February 26, 2026. Accredo operates as a prime contractor providing critical medication distribution services across the VA's nationwide network of Veterans Integrated Service Networks (VISNs), delivering time-sensitive, specialized pharmaceutical treatments to support the healthcare needs of veterans.
Accredo Health Group has generated substantial federal contract volume through numerous firm fixed-price purchase orders issued exclusively by the Department of Veterans Affairs across multiple VISNs, including VISN 1, 2, 4, 5, 6, 9, 12, 16, 20, 21, 22, and 23, with contract values ranging from approximately $1,485 to $184,877 per award. The company supplies a diverse portfolio of specialty medications addressing complex medical conditions, including pulmonary arterial hypertension treatments such as Tyvaso (treprostinil), Uptravi (selexipag), Opsumit (macitentan), and Prolastin; neuropathic lysosomal storage disorder treatments including Lumryz (sodium oxybate); Parkinson's disease medications such as Duopa; ophthalmic conditions treatments including Oxervate (cenegermin) and Oxiviate; and other specialized pharmaceuticals such as Palynziq, Hetlioz (tasimelteon), Filspari, and Tyvasco. Contract awards typically include both routine supply orders and emergency pharmaceutical procurements, with ultimate completion dates generally ranging from one to several months following award. All identified federal contracts are structured as purchase orders without set-aside designations, indicating that Accredo competes on an unrestricted basis for these opportunities. Additionally, Accredo has received a single small contract from the Metropolitan Detention Center Los Angeles for specialty medication delivery valued at $1,485, demonstrating limited diversification beyond VA contracts.
Quick answers
Is Accredo Health Group, Inc. registered in SAM.gov?
Yes. Accredo Health Group, Inc.'s SAM.gov registration is active through January 2, 2027.
How much has Accredo Health Group, Inc. received in federal contracts?
Federal contracts obligated $38,137 to Accredo Health Group, Inc. in fiscal year 2025 and $2,363,547 in fiscal years 2023 through 2027.
How does Accredo Health Group, Inc. rank among federal contractors?
Accredo Health Group, Inc.'s parent company, Express Scripts Inc, ranked #60 in NAICS 325412, #62 in PSC 6505 and #95 in NAICS 3254 in FY2025.
What is Accredo Health Group, Inc.'s most recent federal award?
Accredo Health Group, Inc.'s most recent federal contract award is Pharmacy buy (36C25926P0120), from Veterans Integrated Service Network 19 (VHA), on January 8, 2026.
On GovTribe
See Accredo Health Group, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors